Literature DB >> 27613100

Chemokines, cytokines and exosomes help tumors to shape inflammatory microenvironment.

K-S N Atretkhany1, M S Drutskaya1, S A Nedospasov2, S I Grivennikov3, D V Kuprash4.   

Abstract

Relationship between inflammation and cancer is now well-established and represents a paradigm that our immune response does not necessarily serves solely to protect us from infections and cancer. Many specific mechanisms that link chronic inflammation to cancer promotion and metastasis have been uncovered in the recent years. Here we are focusing on the effects that tumors may exert on inflammatory cascades, tuning the immune system ability to cause tumor promotion or regression. In particular, we discuss the contributions of chemokines, cytokines and exosomes to the processes such as induction of inflammation and tumorigenesis. Overall, tumor-elicited inflammation is a key driver of tumor progression and an essential component of tumor microenvironment. Copyright Â
© 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cancer; Chemokines; Cytokines; Exosomes; Inflammation; Tumor

Mesh:

Substances:

Year:  2016        PMID: 27613100     DOI: 10.1016/j.pharmthera.2016.09.011

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN: 0163-7258            Impact factor:   12.310


  42 in total

Review 1.  Informatics for cancer immunotherapy.

Authors:  J Hammerbacher; A Snyder
Journal:  Ann Oncol       Date:  2017-12-01       Impact factor: 32.976

2.  Inflammatory Components of the Thyroid Cancer Microenvironment: An Avenue for Identification of Novel Biomarkers.

Authors:  Tara Jarboe; Neha Y Tuli; Sanjukta Chakraborty; Rachana R Maniyar; Nicole DeSouza; Augustine Moscatello; Jan Geliebter; Raj K Tiwari
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 3.  NF-κB, inflammation, immunity and cancer: coming of age.

Authors:  Koji Taniguchi; Michael Karin
Journal:  Nat Rev Immunol       Date:  2018-01-22       Impact factor: 53.106

4.  PLCε1 suppresses tumor growth by regulating murine T cell mobilization.

Authors:  M Strazza; K Adam; A V Smrcka; S Lerrer; A Mor
Journal:  Clin Exp Immunol       Date:  2020-01-09       Impact factor: 4.330

5.  Losses of cytokines and chemokines are common genetic features of human cancers: the somatic copy number alterations are correlated with patient prognoses and therapeutic resistance.

Authors:  Henry Sung-Ching Wong; Wei-Chiao Chang
Journal:  Oncoimmunology       Date:  2018-07-30       Impact factor: 8.110

6.  Prognostic value of the pretreatment systemic immune-inflammation index (SII) in patients with non-small cell lung cancer: a meta-analysis.

Authors:  Yan Wang; Yina Li; Pingrun Chen; Wenying Xu; Yanming Wu; Guowei Che
Journal:  Ann Transl Med       Date:  2019-09

Review 7.  The evolving landscape of N6-methyladenosine modification in the tumor microenvironment.

Authors:  Yunru Gu; Xi Wu; Jingxin Zhang; Yuan Fang; Yutian Pan; Yongqian Shu; Pei Ma
Journal:  Mol Ther       Date:  2021-04-09       Impact factor: 11.454

8.  Expanded Expression of Toll-Like Receptor 2 in Proliferative Verrucous Leukoplakia.

Authors:  Joon Koh; Zoya B Kurago
Journal:  Head Neck Pathol       Date:  2019-03-19

Review 9.  Advances in Proteomic Techniques for Cytokine Analysis: Focus on Melanoma Research.

Authors:  Helena Kupcova Skalnikova; Jana Cizkova; Jakub Cervenka; Petr Vodicka
Journal:  Int J Mol Sci       Date:  2017-12-13       Impact factor: 5.923

10.  Salmonella Immunotherapy Improves the Outcome of CHOP Chemotherapy in Non-Hodgkin Lymphoma-Bearing Mice.

Authors:  Thais Bascuas; María Moreno; Sofía Grille; José A Chabalgoity
Journal:  Front Immunol       Date:  2018-01-23       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.